Filing Details
- Accession Number:
- 0001415889-25-009298
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-31 19:24:33
- Reporting Period:
- 2025-03-28
- Filing Date:
- 2025-03-31
- Accepted Time:
- 2025-03-31 19:24:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1484565 | Soleno Therapeutics Inc | SLNO | Electromedical & Electrotherapeutic Apparatus (3845) | 770523891 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1573429 | Matthew Pauls | 100 Marine Parkway, Suite 400 Redwood City CA 94065 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-03-28 | 5,937 | $4.60 | 12,437 | No | 4 | M | Direct | |
Common Stock | Disposition | 2025-03-28 | 5,937 | $71.55 | 6,500 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee stock option (right to buy) | Disposition | 2025-03-28 | 5,937 | $0.00 | 5,937 | $46.31 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
9,063 | 2033-08-15 | No | 4 | M | Direct |
Footnotes
- Certain of these securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
- This transaction was executed in multiple trades at prices ranging from $71.54 to $71.69. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- One forty-eighth (1/48th) of the shares subject to the Option shall vest on September 15, 2023 and each month thereafter on the same day of the month, subject to the Reporting Person continuing to be a Service Provider through each such date.